Synthesis of Novel Ciprofloxacin-Based Hybrid Molecules toward Potent Antimalarial Activity.

ACS Medicinal Chemistry Letters
Srikanta DanaPritam Mukhopadhyay

Abstract

Antimalarial drug resistance is a serious obstacle in the persistent quest to eradicate malaria. There is a need for potent chemical agents that are able to act on drug-resistant Plasmodium falciparum populations at reasonable concentrations without any related toxicity to the host. By rational drug design, we envisaged to address this issue by generating a novel hybrid drug possessing two pharmacophores that can act on two unique and independent targets within the cell. We synthesized a new class of ciprofloxacin-based hybrid molecules, which have been integrated with acridine, quinolone, sulphonamide, and cinnamoyl pharmacophores (1-4). We realized a potent chloroquinolone-ciprofloxacin-based antimalarial hybrid (2, CQ-CFX) whose mechanism of action is unlike that of its parent molecules indicating a unique biological target. CQ-CFX is not only potent against CQ-resistant and susceptible strains of Plasmodium falciparum at low nanomolar concentrations (IC50 values are 63.17 ± 1.2 nM and 25.52 ± 4.45 nM, respectively) but is also not toxic to mammalian and bacterial systems up to 20 μM and 1 μM, respectively.

References

Apr 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·D E GoldbergG B Henderson
Mar 1, 1989·The American Journal of Tropical Medicine and Hygiene·T G GearyJ B Jensen
Oct 1, 1989·Clinical Microbiology Reviews·J S Wolfson, D C Hooper
Aug 1, 1988·Antimicrobial Agents and Chemotherapy·A A DivoF J Bia
Jun 6, 1996·Nature·G I McFaddenN Lang-Unnasch
Jan 1, 1997·Annual Review of Microbiology·S E FrancisD E Goldberg
Dec 6, 1997·Nature·M E Fichera, D S Roos
Dec 20, 1999·Drugs·D C Hooper
Apr 26, 2003·Bioorganic & Medicinal Chemistry·Christian HubschwerlenHans H Locher
Sep 27, 2005·Current Drug Targets. Infectious Disorders·Guillaume AnquetinPierre Vierling
Feb 17, 2006·Journal of Medicinal Chemistry·Chengxin ZhiRichard Storer
Sep 27, 2006·European Journal of Medicinal Chemistry·Guillaume AnquetinPierre Vierling
Feb 10, 2007·Molecular and Biochemical Parasitology·Christopher Dean GoodmanGeoffrey I McFadden
Aug 2, 2007·Accounts of Chemical Research·Bernard Meunier
Aug 19, 2007·Antimicrobial Agents and Chemotherapy·Erica L Dahl, Philip J Rosenthal
Apr 26, 2008·PLoS Pathogens·Dewal JaniDharmendar Rathore
May 14, 2008·Current Pharmaceutical Design·J WiesnerH Jomaa
Sep 17, 2009·Current Pharmaceutical Design·J J Walsh, A Bell
Nov 17, 2009·Journal of Medicinal Chemistry·Faustine DubarChristophe Biot
May 7, 2010·Journal of Medicinal Chemistry·François BellotAnne Robert
Mar 15, 2011·Drug Development Research·Francis W Muregi, Akira Ishih
Mar 9, 2013·Proceedings of the National Academy of Sciences of the United States of America·Monika ChughPawan Malhotra
May 16, 2014·Journal of Medicinal Chemistry·Rudi OliveiraFrancisca Lopes
Jun 6, 2014·ACS Medicinal Chemistry Letters·Daniela MirandaFrancisca Lopes
Jun 26, 2018·ACS Medicinal Chemistry Letters·Tony FröhlichSvetlana B Tsogoeva
May 22, 2020·ACS Medicinal Chemistry Letters·Dionissia A PepeConstantinos M Athanassopoulos

❮ Previous
Next ❯

Citations

Jan 28, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Mélanie FonteCátia Teixeira

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.